Tsukuba, Japan

Kumiko Kawakami


Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 1997-2000

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Kumiko Kawakami: Innovator in Pharmaceutical Chemistry

Introduction

Kumiko Kawakami is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target muscarinic receptors. With a total of 11 patents to her name, her work has the potential to impact various medical treatments.

Latest Patents

One of her latest patents involves N-acyl cyclic amine derivatives. This invention relates to compounds represented by a specific general formula, where the compounds exhibit potent selective antagonistic activity against muscarinic M3 receptors. These compounds are noted for their excellent oral activity, durability of action, and favorable pharmacokinetics. They are considered very useful as safe and effective remedies against respiratory, urinary, and digestive diseases, with minimal adverse side effects. Another area of her research includes substituted amide derivatives, further showcasing her innovative approach to pharmaceutical development.

Career Highlights

Kumiko Kawakami is associated with Banyu Pharmaceutical Co. Ltd., where she has been instrumental in advancing research and development in her field. Her work has not only contributed to the company's portfolio but has also enhanced the understanding of drug interactions and efficacy.

Collaborations

Throughout her career, Kawakami has collaborated with notable colleagues such as Yoshikazu Iwasawa and Tetsuya Aoyama. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kumiko Kawakami's contributions to pharmaceutical chemistry are noteworthy, with her innovative patents paving the way for new treatments. Her dedication to research and collaboration continues to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…